Medical benefits and risks associated with prescription drugs facts and fancy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug development and marketing
1. Verfasser:	Melmon, Kenneth L. (VerfasserIn)
Weitere Verfasser:	Sheiner, Lewis B. (VerfasserIn), Rosenberg, Barr (VerfasserIn)
Format:	UnknownFormat
Veröffentlicht:	1975
Schlagworte:
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Titel	Jahr	Verfasser
Pharmaceutical R & D expenditures and rates of return	1975	Schwartzman, David
The economic and regulatory climate : U.S. and overseas trends	1975	Clymer, Harold A.
Product innovation and the dynamic elements of competition in the ethical pharmaceutical industry	1975	Cocks, Douglas L.
The follow-on development process and the market for diuretics	1975	Kemp, Bernard A.
Developments in the introduction of new drugs in the United States and Britain, 1971-74	1975	Wardell, William M.
Medical benefits and risks associated with prescription drugs : facts and fancy	1975	Melmon, Kenneth L.
The supply response to shifting demand in the ethical pharmaceutical industry	1975	Telser, Lester G.
The diffusion of pharmaceutical innovation	1975	Peltzman, Sam
The rate of new drug discovery	1975	Lasagna, Louis
Profitability measures in the pharmaceutical industry	1975	Stauffer, Thomas R.
The profit rates and economic performance of drug firms	1975	Ayanian, Robert
Coping with illness : choices, alternatives, and consequences	1975	Balter, Mitchell B.